Table 3

Cardiometabolic risk factors at baseline and postintervention for control (N=17) and intervention (N=23) participants†

BaselinePostinterventionMean difference‡ (95% CI)Within-group p valueBetween-group p value (post)
Weight (lbs)0.58
 Control201.4 (30.2)202.4 (30.5)+1.0 (−1.0 to 3.0)0.31
 Intervention194.2 (34.9)194.4 (34.5)+0.2 (−2.3 to 2.7)0.86
BMI (kg/m2)0.76
 Control33.2 (4.5)33.4 (4.6)+0.2 (−0.1 to 0.5)0.21
 Intervention31.8 (5.0)31.9 (5.0)−0.1 (−0.3 to 0.5)0.57
Systolic BP (mm Hg)0.70
 Control117.1 (13.0)117.5 (12.8)−0.8 (−5.0 to 3.6)0.71
 Intervention120.0 (13.8)115.7 (10.8)−4.3 (−8.0 to −0.7)0.02*
Diastolic BP (mm Hg)0.51
 Control72.8 (10.3)73.2 (10.6)−0.1 (−5.0 to 4.8)0.96
 Intervention78.2 (10.3)75.4 (7.4)−2.8 (−6.2 to 0.7)0.11
Waist circumference (cm)0.03**
 Control92.9 (11.1)93.9 (10.8)+1.0 (−0.7 to 2.7)0.22
 Intervention92.6 (11.2)91.6 (11.3)−1.0 (−2.1 to 0.3)0.06
Estimated V02 (mL/kg/min)0.10
 Control29.6 (2.5)30.0 (2.6)+0.3 (-0.1 to 0.8)0.14
 Intervention30.8 (5.1)31.1 (4.6)+0.3 (-0.6 to 1.1)0.53
Total cholesterol (mg/dL)0.83
 Control184.4 (25.9)185.0 (18.9)−0.8 (−15.1 to 13.4)0.91
 Intervention191.4 (26.3)189.7 (27.0)+0.7 (−5.9 to 7.2)0.83
HDL (mg/dL)0.65
 Control47.6 (18.4)46.7 (18.9)−0.9 (−6.8 to 5.1)0.76
 Intervention45.7 (17.6)43.7 (16.4)−2.1 (−8.1 to 3.4)0.46
LDL (mg/dL)0.96
 Control111.2 (32.1)120.2 (25.3)+5.4 (−11.3 to 22.1)0.50
 Intervention119.4 (23.2)116.7 (29.4)−3.7 (−12.8 to 5.4)0.41
Triglycerides0.91
 Control130.6 (65.4)131.0 (59.9)+4.7 (−24.0 to 33.3)0.73
 Intervention98.4 (45.2)118.4 (57.3)+18.3 (−0.1 to 36.7)0.05
  • *p<0.05 for within-group change from baseline (paired t test).

  • **p<0.05 for between-group differences at post-intervention (ANCOVA).

  • †Data presented as the mean (SD).

  • ‡Mean change from baseline (95% CI), adjusted for baseline value (ANCOVA).

  • ANCOVA, analysis of covariance; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.